{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T13:10:46Z","timestamp":1779369046124,"version":"3.53.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematological malignancy that remains a clinical challenge because of drug resistance and relapse, necessitating deeper insights into the mechanism of leukemogenesis and progression. Connexin 43 (CX43) modulates tumor growth and metastasis by regulating cell\u2013extracellular matrix interactions and the tumor microenvironment, but its role in T-ALL remains unclear. The study aims to investigate the changes in the expression of CX43 in the context of T-ALL, its effect on patient prognosis, and the underlying mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      To investigate the impact of CX43 on survival and relapse, this study retrieved databases to analyze the differential expression of CX43 between patients with T-ALL and healthy individuals, as well as its prognostic implications. Meanwhile, the\n                      <jats:italic toggle=\"yes\">CX43<\/jats:italic>\n                      -overexpressing (CX43OE) and neurogenic locus notch homolog protein 1 (\n                      <jats:italic toggle=\"yes\">Notch1<\/jats:italic>\n                      )-mutant plasmids were used to develop a primary T-ALL knock-in mouse model and investigate the effects of CX43 on T-ALL\n                      <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                      and\n                      <jats:italic toggle=\"yes\">in vivo<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The overexpression of CX43 significantly promoted the development and progression of T-ALL and suppressed apoptosis by increasing the stemness of T-ALL cells through the upregulation of Rac family small GTPase 1 (RAC1) expression and the promotion of the phosphorylation of the protein kinase B (AKT)\/glycogen synthase kinase 3 beta (GSK3\u03b2) pathway. Targeting the AKT\/GSK3\u03b2 axis attenuated the stemness induced by CX43 overexpression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>These findings suggest that targeting CX43-mediated pathways may help overcome leukemia stem cell-driven relapse and improve treatment outcomes in patients with T-ALL.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/cm9.0000000000004141","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T13:01:54Z","timestamp":1779368514000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Connexin 43 promotes stemness of leukemia cells and chemoresistance in T-cell acute lymphoblastic leukemia via the RAC1\/AKT\/GSK3\u03b2 axis"],"prefix":"10.1097","author":[{"given":"Rui","family":"Ji","sequence":"first","affiliation":[{"name":"Medical Center of Hematology, Institute of Science Innovation for Blood Ecology and Intelligent Cells, The Second Affiliated Hospital of Army Medical University, Chongqing 400037, China"},{"name":"Chongqing Key Laboratory of Hematology and Microenvironment, Chongqing 400037, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihui","family":"An","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Trauma and Chemical Poisoning, Army Medical University, Chongqing 400037, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lichao","family":"Liu","sequence":"additional","affiliation":[{"name":"Medical Center of Hematology, Institute of Science Innovation for Blood Ecology and Intelligent Cells, The Second Affiliated Hospital of Army Medical University, Chongqing 400037, China"},{"name":"Chongqing Key Laboratory of Hematology and Microenvironment, Chongqing 400037, China"},{"name":"State Key Laboratory of Trauma and Chemical Poisoning, Army Medical University, Chongqing 400037, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqi","family":"Wang","sequence":"additional","affiliation":[{"name":"Medical Center of Hematology, Institute of Science Innovation for Blood Ecology and Intelligent Cells, The Second Affiliated Hospital of Army Medical University, Chongqing 400037, China"},{"name":"Chongqing Key Laboratory of Hematology and Microenvironment, Chongqing 400037, China"},{"name":"State Key Laboratory of Trauma and Chemical Poisoning, Army Medical University, Chongqing 400037, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guancui","family":"Yang","sequence":"additional","affiliation":[{"name":"Medical Center of Hematology, Institute of Science Innovation for Blood Ecology and Intelligent Cells, The Second Affiliated Hospital of Army Medical University, Chongqing 400037, China"},{"name":"Chongqing Key Laboratory of Hematology and Microenvironment, Chongqing 400037, China"},{"name":"State Key Laboratory of Trauma and Chemical Poisoning, Army Medical University, Chongqing 400037, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianjing","family":"Cheng","sequence":"additional","affiliation":[{"name":"Medical Center of Hematology, Institute of Science Innovation for Blood Ecology and Intelligent Cells, The Second Affiliated Hospital of Army Medical University, Chongqing 400037, China"},{"name":"Chongqing Key Laboratory of Hematology and Microenvironment, Chongqing 400037, China"},{"name":"State Key Laboratory of Trauma and Chemical Poisoning, Army Medical University, Chongqing 400037, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longfei","family":"Yang","sequence":"additional","affiliation":[{"name":"Medical Center of Hematology, Institute of Science Innovation for Blood Ecology and Intelligent Cells, The Second Affiliated Hospital of Army Medical University, Chongqing 400037, China"},{"name":"Chongqing Key Laboratory of Hematology and Microenvironment, Chongqing 400037, China"},{"name":"State Key Laboratory of Trauma and Chemical Poisoning, Army Medical University, Chongqing 400037, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maihong","family":"Wang","sequence":"additional","affiliation":[{"name":"Medical Center of Hematology, Institute of Science Innovation for Blood Ecology and Intelligent Cells, The Second Affiliated Hospital of Army Medical University, Chongqing 400037, China"},{"name":"Chongqing Key Laboratory of Hematology and Microenvironment, Chongqing 400037, China"},{"name":"State Key Laboratory of Trauma and Chemical Poisoning, Army Medical University, Chongqing 400037, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyi","family":"Liu","sequence":"additional","affiliation":[{"name":"Medical Center of Hematology, Institute of Science Innovation for Blood Ecology and Intelligent Cells, The Second Affiliated Hospital of Army Medical University, Chongqing 400037, China"},{"name":"Chongqing Key Laboratory of Hematology and Microenvironment, Chongqing 400037, China"},{"name":"State Key Laboratory of Trauma and Chemical Poisoning, Army Medical University, Chongqing 400037, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changzheng","family":"Li","sequence":"additional","affiliation":[{"name":"Medical Center of Hematology, Institute of Science Innovation for Blood Ecology and Intelligent Cells, The Second Affiliated Hospital of Army Medical University, Chongqing 400037, China"},{"name":"Chongqing Key Laboratory of Hematology and Microenvironment, Chongqing 400037, China"},{"name":"State Key Laboratory of Trauma and Chemical Poisoning, Army Medical University, Chongqing 400037, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Dou","sequence":"additional","affiliation":[{"name":"Department of Hematology, Children\u2019s Hospital of Chongqing Medical University, Chongqing 400014, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijie","family":"Yang","sequence":"additional","affiliation":[{"name":"Medical Center of Hematology, Institute of Science Innovation for Blood Ecology and Intelligent Cells, The Second Affiliated Hospital of Army Medical University, Chongqing 400037, China"},{"name":"Chongqing Key Laboratory of Hematology and Microenvironment, Chongqing 400037, China"},{"name":"State Key Laboratory of Trauma and Chemical Poisoning, Army Medical University, Chongqing 400037, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Medical Center of Hematology, Institute of Science Innovation for Blood Ecology and Intelligent Cells, The Second Affiliated Hospital of Army Medical University, Chongqing 400037, China"},{"name":"Chongqing Key Laboratory of Hematology and Microenvironment, Chongqing 400037, China"},{"name":"State Key Laboratory of Trauma and Chemical Poisoning, Army Medical University, Chongqing 400037, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"key":"R1-20260521","article-title":"Consensus on the monitoring, treatment, and prevention of leukaemia relapse after allogeneic haematopoietic stem cell transplantation in China: 2024 update","volume":"605","author":"Tang","year":"2024","journal-title":"Cancer Lett"},{"key":"R2-20260521","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/CM9.0000000000002945","article-title":"Current assessment and management of measurable residual disease in patients with acute lymphoblastic leukemia in the setting of CAR-T-cell therapy","volume":"137","author":"Lin","year":"2024","journal-title":"Chin Med J"},{"key":"R3-20260521","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1097\/CM9.0000000000002235","article-title":"Current status and prospects of hematopoietic stem cell transplantation in China","volume":"135","author":"Wang","year":"2022","journal-title":"Chin Med J"},{"key":"R4-20260521","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S0140-6736(25)00864-5","article-title":"Acute lymphocytic leukaemia","volume":"406","author":"Kantarjian","year":"2025","journal-title":"Lancet"},{"key":"R5-20260521","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s44466-025-00008-y","article-title":"HLA haploidentical HSCT: From immune imbalance to a platform for immune homeostasis restoration","volume":"1","author":"Guo","year":"2025","journal-title":"Immun Inflamm"},{"key":"R6-20260521","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13045-024-01659-x","article-title":"Multinational retrospective analysis of bridging therapy prior to chimeric antigen receptor t cells for relapsed\/refractory acute lymphoblastic leukemia in children and young adults","volume":"18","author":"Breidenbach","year":"2025","journal-title":"J Hematol Oncol"},{"key":"R7-20260521","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s40164-025-00633-8","article-title":"The clinical landscape of CAR NK cells","volume":"14","author":"J\u00f8rgensen","year":"2025","journal-title":"Exp Hematol Oncol"},{"key":"R8-20260521","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40164-024-00592-6","article-title":"Safety and efficacy of CD33-targeted CAR-NK cell therapy for relapsed\/refractory AML: Preclinical evaluation and phase I trial","volume":"14","author":"Huang","year":"2025","journal-title":"Exp Hematol Oncol"},{"key":"R9-20260521","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1182\/blood.2024024072","article-title":"Loss of the stress sensor GADD45A promotes stem\u00a0cell activity and ferroptosis resistance in LGR4\/HOXA9-dependent AML","volume":"144","author":"Hassan","year":"2024","journal-title":"Blood"},{"key":"R10-20260521","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/CM9.0000000000002554","article-title":"Connexin 43-modified bone marrow stromal cells reverse the imatinib resistance of K562 cells via Ca 2+ -dependent gap junction intercellular communication","volume":"136","author":"Li","year":"2023","journal-title":"Chin Med J"},{"key":"R11-20260521","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13045-015-0212-7","article-title":"All-trans retinoic acid arrests cell cycle in leukemic bone marrow stromal cells by increasing intercellular communication through connexin 43-mediated gap junction","volume":"8","author":"Liu","year":"2015","journal-title":"J Hematol Oncol"},{"key":"R12-20260521","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1186\/s13287-024-04079-3","article-title":"CX43-mediated mitochondrial transfer maintains stemness of KG-1a leukemia stem cells through metabolic remodeling","volume":"15","author":"Fu","year":"2024","journal-title":"Stem Cell Res Ther"},{"key":"R13-20260521","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1158\/2159-8290.CD-23-0437","article-title":"GTP signaling links metabolism, DNA repair, and responses to genotoxic stress","volume":"14","author":"Zhou","year":"2024","journal-title":"Cancer Discov"},{"key":"R14-20260521","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100906","article-title":"CCT251545 enhances drug delivery and potentiates chemotherapy in multidrug-resistant cancers by RAC1-mediated macropinocytosis","volume":"66","author":"Qin","year":"2023","journal-title":"Drug Resist Updat"},{"key":"R15-20260521","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/nm.4379","article-title":"Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT-mTORC1 activation","volume":"23","author":"Zhang","year":"2017","journal-title":"Nat Med"},{"key":"R16-20260521","article-title":"A metabolic reprogramming amino acid polymer as an immunosurveillance activator and leukemia targeting drug carrier for T-Cell acute lymphoblastic leukemia","volume":"9","author":"Li","year":"2022","journal-title":"Adv Sci (Weinh)"},{"key":"R17-20260521","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/CM9.0000000000002554","article-title":"Connexin 43-modified bone marrow stromal cells reverse the imatinib resistance of K562 cells via Ca2+-dependent gap junction intercellular communication","volume":"136","author":"Li","year":"2023","journal-title":"Chin Med J"},{"key":"R18-20260521","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.jhep.2020.12.031","article-title":"Mitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinoma","volume":"74","author":"Raggi","year":"2021","journal-title":"J Hepatol"},{"key":"R19-20260521","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1182\/blood.2024025761","article-title":"GATA2 links stemness to chemotherapy resistance in acute myeloid leukemia","volume":"145","author":"Alikarami","year":"2025","journal-title":"Blood"},{"key":"R20-20260521","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.stem.2025.02.006","article-title":"PSPC1 bridges cancer stemness and malignancy in acute myeloid leukemia","volume":"32","author":"Yeh","year":"2025","journal-title":"Cell Stem Cell"},{"key":"R21-20260521","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12943-020-01173-x","article-title":"Verification of EZH2 as a druggable target in metastatic uveal melanoma","volume":"19","author":"Jin","year":"2020","journal-title":"Mol Cancer"},{"key":"R22-20260521","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41392-022-00908-0","article-title":"Clinical utility of PDX cohorts to reveal biomarkers of intrinsic resistance and clonal architecture changes underlying acquired resistance to cetuximab in HNSCC","volume":"7","author":"Yao","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"R23-20260521","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1200\/JCO.19.01027","article-title":"MK-2206 and standard neoadjuvant chemotherapy improves response in patients with human epidermal growth factor receptor 2-positive and\/or hormone receptor-negative breast cancers in the I-SPY 2 trial","volume":"38","author":"Chien","year":"2020","journal-title":"J Clin Oncol"},{"key":"R24-20260521","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1200\/JCO.24.00427","article-title":"US food and drug administration approval summary: Capivasertib with fulvestrant for hormone receptor-positive, human epidermal growth factor receptor 2-negative locally advanced or metastatic breast cancer with PIK3CA\/AKT1\/PTEN alterations","volume":"42","author":"Dilawari","year":"2024","journal-title":"J Clin Oncol"},{"key":"R25-20260521","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1038\/s41375-025-02694-4","article-title":"Superoxide-mediated phosphorylation and stabilization of Mcl-1 by AKT underlie venetoclax resistance in hematologic malignancies","volume":"39","author":"Chong","year":"2025","journal-title":"Leukemia"},{"key":"R26-20260521","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1038\/s41375-024-02401-9","article-title":"Potent combination benefit of the AKT inhibitor capivasertib and the BCL-2 inhibitor venetoclax in diffuse large B cell lymphoma","volume":"38","author":"Willis","year":"2024","journal-title":"Leukemia"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000004141","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T13:01:59Z","timestamp":1779368519000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000004141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":26,"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000004141","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"assertion":[{"value":"2025-05-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}}]}}